2 results for “Tocilizumab”

Set a search alert

Research ArticleOpen accessEvery word in the titleMaternal and Fetal Outcome of COVID Positive Antenatal Women Treated With Tocilizumab in a Tertiary Care Center an Observational Cohort StudyJaimie T Jacob, S Lakshmi Vinodh, Aravind R et al.Tocilizumab, an IL-6 receptor inhibitor, halts the inflammatory stage of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. However, there is little information on Tocilizumab's effects on antenatal women and new born. This study aims to assess the effects of Tocilizumab in treating antenatal women with severe COVID infection. To assess and compare the maternal and fetal outcomes of COVID … …American Journal of Infectious Diseases, Vol. 22, Issue 1 · 14 Sep 2026 · 654 accessesView PDF Cite

Research ArticleOpen accessIn the abstractCharacteristics and Incidence of Candidemia in Hospitalized Coronavirus 2019 (COVID-19) PatientsNaana A Boachie, Jackie P. Johnston, Simi A. Philip et al.Management of Coronavirus 2019 (COVID-19) with high-dose corticosteroids and interleukin-2 inhibitors has potential benefits, but is associated with immunosuppression and risk of secondary infections. This single-center, retrospective, cohort study evaluated the incidence of candidemia and associated risk factors in hospitalized COVID-19 patients. Twenty-three patients developed candidemia and were matched to 77 non-candidemic COVID-19 controls. The primary outcome was incidence of … …American Journal of Infectious Diseases, Vol. 18, Issue 1 · 18 Jan 2022 · 7,598 accessesView PDF Cite